Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.27CNY
1.78 BCNY
7.93 BCNY
4.04 B
About S/H RAAS BLOOD PRO
Sector
Industry
CEO
Jun Xu
Website
Headquarters
Shanghai
Employees (FY)
3.37 K
Founded
1988
ISIN
CNE100000C31
FIGI
BBG000VGJD82
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
An aggregate view of professional's ratings.
Frequently Asked Questions
The current price of 002252 is 6.60 CNY — it has decreased by −0.45% in the past 24 hours. Watch S/H RAAS BLOOD PRO stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange S/H RAAS BLOOD PRO stocks are traded under the ticker 002252.
002252 stock has fallen by −0.15% compared to the previous week, the month change is a −11.41% fall, over the last year S/H RAAS BLOOD PRO has showed a −4.07% decrease.
002252 reached its all-time high on Nov 24, 2015 with the price of 26.67 CNY, and its all-time low was 1.63 CNY and was reached on Oct 17, 2008. View more price dynamics on 002252 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
002252 stock is 1.68% volatile and has beta coefficient of 1.34. Track S/H RAAS BLOOD PRO stock price on the chart and check out the list of the most volatile stocks — is S/H RAAS BLOOD PRO there?
Today S/H RAAS BLOOD PRO has the market capitalization of 42.97 B, it has decreased by −1.21% over the last week.
Yes, you can track S/H RAAS BLOOD PRO financials in yearly and quarterly reports right on TradingView.
S/H RAAS BLOOD PRO is going to release the next earnings report on Oct 24, 2024. Keep track of upcoming events with our Earnings Calendar.
002252 earnings for the last quarter are 0.10 CNY per share, whereas the estimation was 0.10 CNY resulting in a 0.00% surprise. The estimated earnings for the next quarter are 0.10 CNY per share. See more details about S/H RAAS BLOOD PRO earnings.
002252 net income for the last quarter is 483.98 M CNY, while the quarter before that showed 756.82 M CNY of net income which accounts for −36.05% change. Track more S/H RAAS BLOOD PRO financial stats to get the full picture.
Yes, 002252 dividends are paid annually. The last dividend per share was 0.03 CNY. As of today, Dividend Yield (TTM)% is 0.46%. Tracking S/H RAAS BLOOD PRO dividends might help you take more informed decisions.
S/H RAAS BLOOD PRO dividend yield was 0.38% in 2023, and payout ratio reached 11.28%. The year before the numbers were 0.47% and 10.76% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 20, 2024, the company has 3.37 K employees. See our rating of the largest employees — is S/H RAAS BLOOD PRO on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. S/H RAAS BLOOD PRO EBITDA is 2.47 B CNY, and current EBITDA margin is 31.31%. See more stats in S/H RAAS BLOOD PRO financial statements.
Like other stocks, 002252 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade S/H RAAS BLOOD PRO stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So S/H RAAS BLOOD PRO technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating S/H RAAS BLOOD PRO stock shows the strong sell signal. See more of S/H RAAS BLOOD PRO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.